Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults

NEW YORK--(BUSINESS WIRE) February 28, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that available data is...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials